![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Schoen John C Erlandson Kristine M Anderson Peter L
Publisher: Informa Healthcare
ISSN: 1742-5255
Source: Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.5, 2013-05, pp. : 573-588
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Implications of CNS Penetration of Antiretroviral Drugs
By Wynn H.E.
CNS Drugs, Vol. 16, Iss. 9, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Bazzoli Caroline Jullien Vincent > Rey Elisabeth Mentré France Taburet Anne-Marie
Clinical Pharmacokinetics, Vol. 49, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics of Drugs Used to Treat Urge Incontinence
By Guay D.R.P.
Clinical Pharmacokinetics, Vol. 42, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clinical Pharmacokinetics of the Newer Neuromuscular Blocking Drugs
By Paul D. Atherton L. Hunter J.M.
Clinical Pharmacokinetics, Vol. 36, Iss. 3, 1999-03 ,pp. :